Clinical Trials
4 trialsNCT01233687 2017-06-22
AMG 102 and Erlotinib for Advanced Non-Small Cell Lung Cancer
University of Pittsburgh
Phase 1/2 Completed
NCT02015728 2016-12-15
SEED
Seattle Children's Hospital
Phase NA Unknown
NCT01515969 2016-07-12
Phase 1 Erlotinib and Dovitinib (TKI258) in Advanced Non-small Cell Lung Cancer (NSCLC)
Stanford University
Phase 1 Terminated
NCT01189435 2015-11-18
Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib
Memorial Sloan Kettering Cancer Center
Phase 2 Terminated